NEI Podcast

What led you to pursue a career in auditory neuroscience and what is the mission behind your laboratory, Brainvolts? What is the effect of bilingualism on Alzheimer’s disease? How can sound be used for the assessment of traumatic brain injury and other neurological conditions? In this episode, Dr. Nina Kraus addresses these questions and much more about the clinical applications for auditory neuroscience research. Her laboratory at Northwestern University, Brainvolts, has discovered how to measure the biology of auditory processing with unprecedented precision. The implications of the research conducted there extends beyond the laboratory to schools, community centers, and clinics. Nina Kraus, Ph.D. is a professor at Northwestern University who studies the biology of auditory learning. Through a series of innovative studies involving thousands of research participants from birth to age 90, her research has found that our lives in sound, for better (musicians, bilinguals) or worse (language disorders, concussion, aging, hearing loss), shape auditory processing. She continues to conduct parallel experiments in animal models to elucidate the mechanisms underlying these phenomena. Never having accepted a lack of technology as a roadblock to scientific discovery, Kraus has invented new ways to measure the biology of sound processing in humans that provide precision and granularity in indexing brain function. With her technological innovations she is now pushing science beyond the traditional laboratory by conducting studies in schools, community centers, and clinics. Using the principles of neuroscience to improve human communication, she advocates for best practices in education, health, and social policy. Dr. Kraus is the author of the book “Of Sound Mind: How our Brain Constructs a Meaningful Sonic World.” Resources: Brainvolts: https://brainvolts.northwestern.edu/about-us/ Learn more about Of Sound Mind: How our Brain Constructs a Meaningful Sonic World: https://www.amazon.com/Sound-Mind-Brain-Constructs-Meaningful/dp/0262045869# BEAMS hypothesis: https://brainvolts.northwestern.edu/wp-content/uploads/2021/07/Kraus_BEAMS_2021-1.pdf

In this CME episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl and Dr. Sarah Vinson about the ethicality and morality of involuntary treatment for serious mental illness (SMI), the relationship between SMI and the criminal justice system, and community-based changes that are being pursued to improve treatment and reduce the criminalization of SMI.  Create a free NEI guest account and obtain CME/CE by participating in this activity here: https://nei.global/e190-cme  Never miss an episode!🎙SUBSCRIBE to the NEI Podcast– available on all your favorite platforms: https://nei.global/podcast  Interested in Psychopharmacology?  Learn about the NEI Master Psychopharmacology Program: https://nei.global/mpp   Stay updated with email alerts and join our conversations on social. Follow us on:  YouTube: https://nei.global/youtube  Instagram: https://nei.global/instagram  LinkedIn: https://nei.global/linkedin  Facebook: https://nei.global/facebook  X: https://nei.global/twitter 

In this re-release episode, Dr. Andrew Cutler interviews Drs. Marko Perko and Stephen Stahl about their book, Tesla: His Tremendous and Troubled Life, which explores the intersection between Tesla’s genius, his creativity, and his bipolar disorder. Sadly, Dr. Marko Perko passed away last fall after a battle with cancer. He was a prolific writer and a great mind, and we re-release this episode in his honor.   Learn more about Tesla: His Tremendous and Trouble Life

NEI Podcast is taking a temporary hiatus over the summer. From July through September, we will revisit some of our most compelling episodes, on topics that remain as relevant today as when they first aired. New episodes will resume in the fall; make sure you are subscribed so that you don’t miss out!  ***************************** What is unique about collaborative care when it comes to mental health? Can you share some of the step-by-step guide to implementing the core model in clinical practice for collaborative care? In this episode, Dr. Anna Ratzliff answers these questions and much more!   Dr. Anna Ratzliff is a national expert on collaborative care, and specifically on training teams to implement and deliver mental health treatment in primary care settings. Her passion for translating complex research ideas into practical real-world applications began when she received her MD and PhD in Anatomy and Neurobiology as part of the Medical Scientist Training Program at the University of California at Irvine. She currently is a Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington, where she has developed additional expertise in suicide prevention training, mental health workforce development, adult learning best practices, and mentorship. Dr. Ratzliff is the Director of the UW Psychiatry Resident Training Program, Co-Director of the AIMS Center (Advancing Integrated Mental Health Solutions), and Director of the UW Integrated Care Training Program for residents and fellows.  Resources:   AIMS Center Website: http://aims.uw.edu/  Implementation Guide: https://aims.uw.edu/collaborative-care/implementation-guide  APA Training: https://www.psychiatry.org/psychiatrists/practice/professional-interests/integrated-care 

What are some of the greatest challenges when treating ADHD in the elderly population? Are stimulants safe in the elderly population? How do hormonal changes influence ADD or ADHD in women throughout life?  With this special series, brought to you by the NEI Podcast, we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on novel perspectives and novel treatment approaches for Attention Deficit Hyperactivity Disorder (ADHD). Today, Dr. Andy Cutler interviews Dr. David Goodman on treating ADHD across the lifespan. Let’s listen in to Part 3 of our theme: Treating ADHD Across the Lifespan. Subscribe to the NEI Podcast, so that you don’t miss another episode!

What is avoidant/restrictive food intake disorder or ARFID? How does it differ from other disorders? How are intestinal microbiota involved when it comes to eating disorders? Dr. Cynthia Bulik is a Distinguished Professor of Eating Disorders and Founding Director of the University of North Carolina (UNC) Center of Excellence for Eating Disorders and Professor of Nutrition, Gillings School of Global Public Health; and Associate Director, UNC Center for Psychiatric Genomics. Dr. Bulik’s research teams at UNC (Center of Excellence for Eating Disorders-CEED) and Karolinska Institute (Centre for Eating Disorders Innovation-CEDI) are dedicated to deepening our understanding of the underlying biology and genetics of eating disorders and to advancing the evidence base for the treatment of these illnesses. As founder and co-chair of the Eating Disorders Working Group of the Psychiatric Genomics Consortium (PGC-ED), she leads the global effort to identify actionable genomic variation in eating disorders. She is Principal Investigator of the global Eating Disorders Genetics Initiative funded by the National Institute of Mental Health. She is also the Principal Investigator of the largest study of genetic and environmental contributors to avoidant/restrictive food intake disorder (ARFID-GEN), also funded by the National Institute of Mental Health. Together with Ian Carroll, PhD she conducts population-level and intensive longitudinal clinical investigations of the intestinal microbiota in eating disorders. For the past decade, with Donald Baucom, PhD and Jennifer Kirby, PhD she has developed and disseminated a suite of couple-based interventions for anorexia nervosa, bulimia nervosa, and binge-eating disorder (UNITE: UNiting couples In the Treatment of Eating disorders). She also serves as senior faculty on the SAMHSA-funded National Center of Excellence for Eating Disorders (NCEED)—the national authoritative source for information and training in eating disorders. She is dedicated to mentorship of junior investigators, especially women in STEM fields and is passionate about translating science for the public.

What has research demonstrated about the advantages and consequences of telehealth for the treatment of ADHD and mental health? How can we fill the gaps in underserved communities when it comes to telehealth treatment for ADHD? With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on novel perspectives and novel treatment approaches for Attention Deficit Hyperactivity Disorder (ADHD). Today, Dr. Andy Cutler interviews Dr. Greg Mattingly on best practices and guidelines for using telemedicine for the treatment and management of ADHD. Let’s listen in to Part 2 of our theme: The Challenges of Treating ADHD Online Subscribe to the NEI Podcast, so that you don’t miss another episode!

What are common comorbidities with ASD and how difficult is it to differentiate these conditions from overlapping symptoms of ASD? What guidelines are there for managing agitation in autism spectrum disorder? Robyn Thom, MD, is a child, adolescent, and adult psychiatrist at the Massachusetts General Hospital (MGH) Lurie Center for Autism and co-Director of the MGH Williams Syndrome Program. She is also an Assistant Professor of Psychiatry at Harvard Medical School. She specializes in diagnosing and treating comorbid psychiatric conditions in individuals with autism spectrum disorder and other developmental disabilities including Williams syndrome. Dr. Thom's research interests include psychopharmacology, anxiety disorders, Williams syndrome, medical comorbidity in adults with autism spectrum disorder, and brain aging.

What is the proposed neurocircuitry that underlies attention deficit hyperactivity disorder, or ADHD? What is known about the role of serotonin in ADHD? Particularly the 5HT2C and 5HT7 receptors? With this special series, brought to you by the NEI Podcast, we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on novel perspectives and novel treatment approaches for Attention Deficit Hyperactivity Disorder (ADHD). Today, Dr. Andy Cutler interviews Dr. Stephen Stahl on the current state of ADHD and where the future lies. Let’s listen in to Part 1 of our theme: Shifting Focus: A Novel Perspective on Attention Deficit Hyperactivity Disorder (ADHD) Subscribe to the NEI Podcast, so that you don’t miss another episode!

In this episode, Dr. Jonathan Meyer addresses your unanswered questions from his presentation: Dopamine Partial Agonists: How They Work and Why They Don’t Always Play Nice with Other Antipsychotics.